The Genetic Engineering Approval Committee (GEAC) has already held two meetings to discuss the proposal to allow commercial cultivation of a GM hybrid variety DMH-11 of the mustard plant developed by Delhi University's Centre for Genetic Manipulation of Crop Plants (CGMCP).
In its February 5 meeting, CGMCP was to prepare a Risk Assessment and Risk Management (RARM) document and submit within two weeks. It had also recommended a long procedure for "further review and consultation" on the biosafety data.
"By comparing DMH-11 with very old checks or comparators, the crop developers are trying to show exaggerated benefits. It has not been compared with other hybrids like DMH-1," claimed National Academy of Agricultural Sciences (NAAS) Fellow Sharad Pawar in a press conference.
Alleging that DMH-11 testing was rigged to enable claims of yield benefits, Coalitions said: "However, compared with other extensively tested cultivators, GM mustard actually produces 10.4 per cent to 27.5 per cent lesser yields. Regulatory assessment should focus not only on risks which are being under-reported but also on benefits which are falsely-constructed."
